Health experts are warning people against a dangerous microdosing trend where people take smaller doses than prescribed and ...
Single-use and reusable needle-free injection devices will be designed for precise self-administration and home use. PharmaJet injector pens are intended for needle-free subcutaneous delivery of a ...
A pharmacy expert has warned that following the latest weight loss medication trend could pose serious health risks including ...
The MarketWatch News Department was not involved in the creation of this content. -- Single-use and reusable needle-free injection devices will be designed for precise self-administration and home use ...
Eli Lilly said today it has begun selling vials of the lowest starter dose of its popular weight-loss drug Zepbound in the United States for $399 for a month’s supply through its direct-to-consumer ...
Over the last few years, the interest in GLP-1 drugs for weight loss has skyrocketed. Currently, the most common delivery system for GLP-1 medications is through pre-filled injection pens designed to ...
If you’re considering a semaglutide medication like Ozempic or Wegovy for weight loss, you may be a bit worried about the weekly injections. Both medications come in a pre-filled pen so you can inject ...
Jason Murphy, Head of Pharmacy and weight loss specialist at Chemist4U, cautioned: "One of the greatest problems that can ...
Owen Mumford has released a new injection pen training video. Developed in collaboration with consultant pharmacists and nursing professionals, the video addresses critical steps when clinically ...
Starter doses of the weight-loss drug Zepbound are now available in single-dose vials, drug manufacturer Eli Lilly announced Tuesday, a move the company says will “significantly” expand supply as it ...
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. What Happens If You Use Expired Semaglutide? Wondering what ...
About half of adults who take a GLP-1 drug say it’s difficult to afford. (Leila Register / NBC News; Getty Images) Over the past several months, however, drugmakers Novo Nordisk and Eli Lilly have ...